Microcarrier Market Size to Hit Around USD 5.10 Billion by 2030

According to Vision Research Reports, the global microcarrier market size is expected to hit around USD 5.10 billion by 2030 and growing at a CAGR of 11.4% from 2022 to 2030.

Immediate Delivery Available | Get the sample copy of report@ https://www.visionresearchreports.com/report/sample/39792

Microcarrier is a small bead-like material used to immobilize biocatalysts or to adhere to the growing cells to be cultivated in bioreactors. It acts like a support matrix. The cells grow on the microcarriers which are spherical and called beads. It provides the approach for the expansion of the cell culture system which is beneficial for gene and cell-based therapies and research activities. Microcarrier has wide application in vaccine production using packaging cell lines. The most commonly used cell types are Vero cells. Microarray technology also has advantages in the pharmaceutical and biotech sector, as follows –

• Easy scale-up process
• Ability to control the conditions of cell growth for the advanced bioreactors which are computer-controlled
• Reduced technical labor
• Providing natural environment for the cell culture

Scope of The Report

Vaccine production and cell therapy are the major driving factors for enhancing the growth of microcarrier markets. Vaccines produced from microcarriers or cell cultures is the most efficient method as the process has a short lead time and large production quantity. Clinical trials have also proved that this is a safe and effective process. Moreover, the funding from the private as well as public sector companies is increasing for cell-based vaccine production. The commercially available microcarriers in the market are alginate-based, dextran-based, collagen-based, and polystyrene-based. Some examples of such microcarriers are GEM, Cytodex, GE Healthcare, Cultispher, Percell, and SoloHill Engineering. On the other hand, the downstream process cost of the microcarrier culture is high. This can be one of the restraints for the microcarrier markets for small-scale companies with low budgets. Recently, Sartorius Stedim Biotech (SSB) launched a mini bioreactor vessel for the production of vaccines using microcarrier cell culture. The rise in cancer cases which is observed globally is boosting the growth of markets.

The market is segmented based on product type, application, end-user, and region. The market is segmented based on the product type into equipment, consumables, and microcarrier beads. Based on the application segment it is further segmented into gene therapy, vaccine manufacturing, biologics manufacturing, tissue engineering, and regenerative medicines among others. End users like pharmaceutical and biotechnology industries, CROs, and Research Institutes hold the major markets as they contribute to the invention, discovery, and improvement of human lives.

Based on region, the market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle East and Africa. As per the research, North America holds the major market due to the higher prevalence of chronic diseases. Also, North America has a well-developed healthcare infrastructure and growing healthcare sector which contributes to the market growth. This is due to the increasing investments and funding by private and public companies along with research institutes. The European market is also projected to expand due to increasing investment by companies in the region. Recently, Sartorius, Germany has obtained the SoloHill portfolio of Danaher Corporation, thus expanding its microcarrier portfolio. The company has also introduced a mini microcarrier bioreactor vessel. ABL Europe and Sartorius have signed an agreement for implementing the manufacturing facility in Strasbourg.

Market Growth Drivers

Rising Demands for Therapeutically Efficient Vaccine to Stimulate Market Growth

The global microcarrier market growth is expected to develop during the forecast period due to the increasing demands for efficient vaccines and drugs. Increasing demands for therapeutically efficient vaccines are expected to drive the market. The rising prevalence of various diseases is likely to enhance product demand for appropriate treatments. In contrast, high investments required for cell biology research are likely to hinder market growth. 

Immediate Delivery Available | Buy this Premium Research Report@ https://www.visionresearchreports.com/report/cart/39792

Key Market Trends

Cell Therapy is Expected to Show Fastest Growth by Application, Over the Forecast Period

Microcarriers help in cost-effective cell production i.e they contribute to reducing fixed as well as variable costs during the large scale manufacturing. With technological advancements, the current scenario has changed and the significance of microcarriers in cell therapy has increased. For instance, dissolvable microcarriers are currently there in the market that is composed of cross-linked polysaccharide polymers that can be efficiently dissolved during the cell harvest step. As the microcarriers get completely dissolved, there is no need for the separation and simply, the downstream process goes well. Therefore, these microcarriers are considered as beneficial beads for large scale cell production or cell therapy application.

Along with the above-mentioned statements, another factor that is responsible for the growth of cell therapy applications of microcarriers is that companies are currently focusing on the provision of microcarriers that contribute to the large scale and cost-effective production. For example Corning Incorporated provides dissolvable microcarriers. These factors boost the growth in cell therapy applications.

Key Players

• Sartorius AG
• GE Healthcare
• Thermo Fisher Scientific Inc.
• Corning Incorporated
• Merck KGaA
• Danaher Corporation
• Lonza
• Eppendorf AG
• Becton
• Dickinson and Company
• HiMedia Laboratories
• others

Market Segmentation

• By Product Type
  •  Equipment
  • Consumables
    • Media
    • Reagents
  • Microcarrier Beads
• By Application
  • Vaccine Manufacturing
  • Cell and Gene Therapy 
  • Biologics
  • Manufacturing
  • Tissue Engineering
  • Others
• By End-user
  • Academic and Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations
• By Region
  • North America
  • Europe 
  • Asia-Pacific
  • Latin America
  • Middle East And Africa

Click Here to View Full Report Table of Contents

Immediate Delivery Available | Buy this Premium Research Report@ https://www.visionresearchreports.com/report/cart/39792

You can place an order or ask any questions, please feel free to contact at sales@visionresearchreports.com | +1 9197 992 333

Blog: https://www.novaoneadvisor.com/

Blog: https://qyresearchmedical.com/